Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Department of Justice DOJ

Cardiologists at heart of alleged kickback scheme—imaging provider, CEO to pay $85M to settle

The allegations revolve around payments referring cardiologists received to supervise PET scans from March 2014 to May 2023.

Timothy Bateman, MD, co-director, cardiovascular radiologic imaging program, Saint Luke's Mid America Heart Institute, professor of medicine at the University of Missouri-Kansas City School of Medicine, and an ASNC past-president, is one of the authors on the AURORA study. He spoke with Cardiovascular Business about the study and what it is like to work with flurpiridaz.

Flurpiridaz will have a major impact on cardiac PET and nuclear imaging

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

Video of Christina Albert, MD, MPH chair, Department of Cardiology, Cedars-Sinai, explaining the changing approaches to sudden cardiac arrest. #SCA #SCD #ESC #ESC23 #ESC2023

Changing approaches to the treatment of sudden cardiac arrest

Preventing sudden cardiac arrest involves managing risk factors such as hypertension, hyperlipidemia and diabetes. We spoke to Christine Albert, MD, about this and much more at ESC 2023.

Video of Brian Ghoshhajra, MD, Mass General, explaining some of the top trends in cardiac CT from SCCT 2023 meeting. #SCCT #SCCT23 #SCCT2023 #YesCCT

Top trends in cardiac CT from SCCT 2023

Cardiac CT has been evolving rapidly in recent years. Brian Ghoshhajra, MD, outlined some of the main trends he has seen at the 2023 annual meeting of the Society of Cardiovascular Computed Tomography.

Gregg Stone, MD, discussing the value of IVUS and OCT over angiography along to guide PCI procedures and actually improve outcomes based on a 12,000 patient meta analysis presented at ESC 2023. #ESC #ESC23 #ESC2023

Intravascular imaging improves PCI outcomes in meta analysis

Gregg Stone, MD, discussing the value of IVUS and OCT over angiography to guide PCI procedures and actually improve outcomes based on a 12,000 patient meta analysis presented at ESC 2023.

Artificial intelligence (AI) is being developed to help make cardiovascular clinical trials more efficient, lead to faster advances in patient care, and bring possible new treatments to heart patients more quickly. The major cardiac research center of Icahn School of Medicine at Mount Sinai announced today that it signed a memorandum of understanding with the Chiba Institute of Technology (CIT) to collaborate on using AI to enhance cardiovascular disease research.

Mount Sinai partners with the Chiba Institute of Technology on AI to transform cardiovascular research 

Agreement aims to use AI to help make cardiology clinical trials more efficient and lead to faster advances in patient care. 

Video interviuew with Ginger Biesbrock, DSc, PA-C, FACC, executive vice president of MedAxiom, on the "Financial Impact of Cardiac CT to the Cardiovascular Service Line" report at SCCT 2023. #SCCT #YesCCT #Medaxiom

Cardiac CT's financial impact on the cardiovascular service line

Implementing cardiac CT can make a big impact across the service line without reducing the use of other modalities. Ginger Biesbrock, MedAxiom's executive vice president, explained these findings in a new video interview.

Thumbnail

Complex PCI among older patients linked to increased risk of death

“Given the dramatic difference in death risk for older adults receiving complex PCI, we suggest that such interventions in this exceptionally vulnerable population should be approached with additional caution," researchers wrote. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.